ABL Diagnostics continues its surveillance of SARS-CoV-2 variants and prepares for any resurgence of COVID-19 outbreaks
WOIPPY, FRANCE, August 21, 2024 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories today announced its DeepChek® offer …